Themis Medicare logo

Themis Medicare CEO, MD, chairman, board of directors and AGM

NSE: THEMISMEDBSE: 530199Pharmaceuticals & BiotechnologySmall Cap

Last close ₹90.74down ₹3.85 (4.07%)BSE ₹90.35

Share price at the NSE close on 23 Oct 2026. Previous close ₹94.59.

52-week range of traded prices to 23 Oct 2026
₹64.95Low, 30 Mar 2026₹140.60High, 7 Sep 2026
Market cap
₹836 Cr1,570th largest listed
P/E
20.9
P/E without one-offs
Lossover the last 12 months
P/B
2.1
Dividend yield
0.55%
ROE
10.0%
ROE without one-offs
−13.0%
ROCE
−10.5%
Debt to equity
0.25
Volume, NSE
59,57241.2% delivered

Themis Medicare board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonDinesh Shantilal Patel
  • Managing director and CEOSachin Dinesh Patel
  • Company Secretary and Compliance OfficerSuresh Savaliya

9 directors4 independent2 executive3 non-executive

  • Dinesh Shantilal Patel · ChairpersonExecutive · joined Jun 2007 · reappointed Feb 2022 · 2 listed boards · 1 committee seat, 1 as chair
  • Sachin Dinesh Patel · Managing director and CEOExecutive · joined Jun 2007 · reappointed Feb 2022 · 2 listed boards · 4 committee seats
  • Rajneesh Kedarnath AnandNon-executive · joined Apr 2007 · 2 listed boards · 2 committee seats
  • Adam DemeterNon-executive · joined Sep 2023 · 1 listed board
  • Reena Sachin PatelAlternate · joined Sep 2023 · 1 listed board
  • Bhaskar Vemban IyerIndependent · joined Nov 2021 · 59 months as independent · 3 listed boards · 3 as independent · 4 committee seats
  • Shishir Vasant DalalIndependent · joined Sep 2023 · 36 months as independent · 3 listed boards · 3 as independent · 5 committee seats, 2 as chair
  • Nikunt Kirit RavalIndependent · joined Jun 2024 · 27 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
  • Neha Anant ThakoreIndependent · joined Aug 2025 · 14 months as independent · 2 listed boards · 2 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Manjul Sandhu, left 10 Nov 2025: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 13 Aug 20267 of 9 present4 independent · 76 days in between
    • 28 May 20268 of 9 present4 independent

  • Audit Committee

    Chair Shishir Vasant Dalal

    Sachin Dinesh Patel, Bhaskar Vemban Iyer, Nikunt Kirit Raval

    • 13 Aug 20264 of 4 present3 independent · 76 days in between
    • 28 May 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair Shishir Vasant Dalal

    Rajneesh Kedarnath Anand, Nikunt Kirit Raval

    • 13 Aug 20263 of 3 present2 independent · 180 days in between
    • 13 Feb 20263 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair Nikunt Kirit Raval

    Sachin Dinesh Patel, Rajneesh Kedarnath Anand, Bhaskar Vemban Iyer

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Sachin Dinesh Patel

    Bhaskar Vemban Iyer, Neha Anant Thakore, Tushar Dalal

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair Nikunt Kirit Raval

    Sachin Dinesh Patel, Neha Anant Thakore

    No meeting listed in the filing.

  • Preferential Issue Committee

    Chair Shishir Vasant Dalal

    Nikunt Kirit Raval, Rajneesh Kedarnath Anand

    • 24 Sep 20263 of 3 present2 independent · 41 days in between

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • KRISHAAN AND COPeer-review certificate valid to Jul 2027
1 earlier auditor
  • KRISHAAAN AND CONamed in the filing for the quarter to Sep 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Themis Medicare AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Themis Medicare dividend history

Annual general meeting, 30 Sep 2026

20,503 shareholders on the register on 23 Sep 2026; present: 11 promoters and 27 others; votes counted by Ketan Ravindra Shriwadkar / KRS AND CO.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026, together with Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 39.21% · promoters 57.47% · institutions 57.13% · other public 1.92%

  2. To appoint a Director in place of Mr. Rajneesh Anand (DIN: 00134856) who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 7.95% · other public 0.03%

    Turnout: all 39.21% · promoters 57.47% · institutions 57.13% · other public 1.92%

  3. To declare dividend on equity shares for the financial year ended 31st March, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 39.21% · promoters 57.47% · institutions 57.13% · other public 1.92%

  4. Ratification of Remuneration of Cost Auditor for the financial year 2026-27.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 39.21% · promoters 57.47% · institutions 57.13% · other public 1.92%

  5. Amendment to the Articles of Association of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 39.21% · promoters 57.47% · institutions 57.13% · other public 1.92%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Mar 2026, 4 resolutions

22,659 shareholders on the register on 25 Feb 2026; votes counted by Mr. Abhishek Wagh / M/s. Abhishek Wagh & Associates.The company's voting result (opens in a new tab)

  1. APPROVAL OF MATERIAL RELATED PARTY TRANSACTIONS WITH THEMIS DISTRIBUTORS PRIVATE LIMITED OR WITH VIVIDHMARGI INVESTMENTS PRIVATE LIMITED (VMIPL), TRANSFEREE COMPANY, POST MERGER
    OrdinaryPromoters have an interest in it
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 3.31% · other public 0.05%

    Turnout: all 5.10% · promoters 0.00% · institutions 57.93% · other public 15.40%

  2. 2 - APPROVAL OF MATERIAL RELATED PARTY TRANSACTIONS WITH GUJARAT THEMIS BIOSYN LIMITED (GTBL).
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 5.10% · promoters 0.00% · institutions 57.93% · other public 15.40%

  3. APPROVAL OF MATERIAL RELATED PARTY TRANSACTIONS WITH DR. SACHIN D. PATEL UP TO RS. 130 CRORES IN RESPECT OF PROMOTERS INTER-SE TRANSFER OF EQUITY SHARES OF GUJARAT THEMIS BIOSYN LIMITED (GTBL) HELD BY THEMIS MEDICARE LIMITED (TML).MoreLess
    OrdinaryPromoters have an interest in it
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 3.31% · other public 0.10%

    Turnout: all 5.10% · promoters 0.00% · institutions 57.93% · other public 15.40%

  4. APPROVAL OF ISSUANCE OF CONVERTIBLE WARRANTS TO VIVIDHMARGI INVESTMENTS PRIVATE LIMITED, PROMOTER GROUP COMPANY ON PREFERENTIAL BASIS
    SpecialPromoters have an interest in it
    99.65% for0.35% against

    Against: promoters 0.00% · institutions 3.31% · other public 0.50%

    Turnout: all 7.66% · promoters 3.81% · institutions 57.93% · other public 15.40%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 12 Sep 2025, 7 resolutions

20,864 shareholders on the register on 5 Sep 2025; present: 10 promoters and 45 others; votes counted by Mr. Shirish Shetye / SAV & Associates LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2025, together with the Auditors’ Report and Directors’ Report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 61.28% · promoters 90.38% · institutions 52.15% · other public 1.63%

  2. To appoint a Director in place of Dr. Adam Demeter (DIN: 10283162) who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 93.90% · other public 0.02%

    Turnout: all 61.28% · promoters 90.38% · institutions 52.15% · other public 1.63%

  3. To declare a dividend for the financial year ended 31st March, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 61.28% · promoters 90.38% · institutions 52.15% · other public 1.63%

  4. Ratification of Remuneration of Cost Auditor for the Financial Year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 61.27% · promoters 90.38% · institutions 52.15% · other public 1.62%

  5. Appointment of Secretarial Auditor
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 61.27% · promoters 90.38% · institutions 52.15% · other public 1.62%

  6. Payment of commission to Non-Executive Directors
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 61.27% · promoters 90.38% · institutions 52.15% · other public 1.60%

  7. Appointment of Ms. Neha Thakore (DIN: 00893957) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 61.27% · promoters 90.38% · institutions 52.15% · other public 1.62%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 22 Mar 2025, 1 resolution

18,258 shareholders on the register on 14 Feb 2025; votes counted by Shirish Shetye / SAV & Associates LLP.The company's voting result (opens in a new tab)

  1. To approve material Related Party Transactions with Themis Distributors Private Limited for the FY 2025-26
    OrdinaryPromoters have an interest in it
    95.66% for4.34% against

    Against: promoters 0.00% · institutions 97.28% · other public 0.07%

    Turnout: all 0.99% · promoters 0.00% · institutions 32.69% · other public 2.90%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 22 Jul 2024, 7 resolutions

Present: 12 promoters and 34 others.The company's voting result (opens in a new tab)

  1. 1- To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March 2024, together with the Auditors’ Report and Directors’ Report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.39%

    Turnout: all 66.84% · promoters 99.10% · institutions 38.16% · other public 0.84%

  2. 2 - To appoint a Director in place of Mr. Rajneesh Anand (DIN: 00134856) who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.39%

    Turnout: all 66.84% · promoters 99.10% · institutions 38.16% · other public 0.84%

  3. 3 - To declare dividend for the financial year ended 31st March, 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.42%

    Turnout: all 66.83% · promoters 99.10% · institutions 38.16% · other public 0.79%

  4. 4 - To ratify the payment of Remuneration to M/s. B. J. D. Nanabhoy & Co., Cost Accountants, Mumbai for conducting Cost Audit of the Company for the financial year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.39%

    Turnout: all 66.84% · promoters 99.10% · institutions 38.16% · other public 0.84%

  5. 5 - Remuneration payable to Dr. Dinesh S. Patel (DIN: 00033273) as a Whole-Time Director designated as “Executive Chairman”.
    SpecialPromoters have an interest in it
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 98.13% · other public 0.39%

    Turnout: all 66.84% · promoters 99.10% · institutions 38.16% · other public 0.84%

  6. 6 - Remuneration payable to Dr. Sachin D. Patel (DIN: 00033353) as Managing Director & CEO.
    SpecialPromoters have an interest in it
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 98.13% · other public 0.39%

    Turnout: all 66.84% · promoters 99.10% · institutions 38.16% · other public 0.84%

  7. 7 - Appointment of Mr. Nikunt Kirit Raval (DIN: 10357559) as an Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.40%

    Turnout: all 66.84% · promoters 99.10% · institutions 38.16% · other public 0.83%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 7 Apr 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. To approve material Related Party Transactions with Themis Distributors Private Limited
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 63.77% · promoters 94.66% · institutions 0.43% · other public 0.64%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 15 Nov 2023, 2 resolutions

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Shishir Dalal (DIN: 00007008) as an Independent Director
    Special
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.00% · other public 22.27%

    Turnout: all 66.80% · promoters 99.10% · institutions 0.00% · other public 0.77%

  2. Appointment of Dr. Adam Demeter (DIN: 10283162) as a Non-Executive Director, liable to retire by rotation
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.00% · other public 21.84%

    Turnout: all 66.80% · promoters 99.10% · institutions 0.00% · other public 0.77%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 9 Sep 2023, 6 resolutions

Present: 7 promoters and 27 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March 2023, together with the Auditors’ Report and Directors’ Report thereon.nnMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.01% · promoters 99.10% · institutions 0.74% · other public 1.41%

  2. To appoint a Director in place of Mr. Rajneesh Anand (DIN: 00134856) who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.01% · promoters 99.10% · institutions 0.74% · other public 1.41%

  3. To declare dividend for the financial year ended 31st March, 2023.n
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.01% · promoters 99.10% · institutions 0.74% · other public 1.41%

  4. To ratify payment of Remuneration to M/s. B. J. D. Nanabhoy & Co., Cost Accountants, Mumbai for conducting Cost Audit of the Company for the financial year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.01% · promoters 99.10% · institutions 0.74% · other public 1.41%

  5. Sub-Division (Stock Split) of equity shares of the Company from the Face Value of Rs. 10/- to Face Value of Rs. 1/- per share
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.01% · promoters 99.10% · institutions 0.74% · other public 1.41%

  6. Alteration of Capital Clause of Memorandum of Association of Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.01% · promoters 99.10% · institutions 0.74% · other public 1.41%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 27 Mar 2026, 2 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • APPROVAL OF MATERIAL RELATED PARTY TRANSACTIONS WITH THEMIS DISTRIBUTORS PRIVATE LIMITED OR WITH VIVIDHMARGI INVESTMENTS PRIVATE LIMITED (VMIPL), TRANSFEREE COMPANY, POST MERGER
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual FundCompliant with law. Governance and Transparency concern: The basis for determining the arm’s length pricing has not been adequately disclosed by the Company.
    • Motilal Oswal Mutual FundInadequate disclosures regarding the basis of determination of arms’ length pricing.
    0 for2 against
  • 2 - APPROVAL OF MATERIAL RELATED PARTY TRANSACTIONS WITH GUJARAT THEMIS BIOSYN LIMITED (GTBL).
    2 for0 against
  • APPROVAL OF MATERIAL RELATED PARTY TRANSACTIONS WITH DR. SACHIN D. PATEL UP TO RS. 130 CRORES IN RESPECT OF PROMOTERS INTER-SE TRANSFER OF EQUITY SHARES OF GUJARAT THEMIS BIOSYN LIMITED (GTBL) HELD BY THEMIS MEDICARE LIMITED (TML).MoreLess
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual FundCompliant with law. Governance and Transparency concern: The Company has not provided an adequate rationale or justification for the proposed transfer/sale of its stake in GTBL to promoter, and it remains unclear how such a transaction qualifies as being in the ordinary course of business of the Company. Further, the Company has sought approval under Section 180 of the Companies Act, 2013 in a cursory manner, without furnishing complete particulars; it further remains unclear that, if the Company intends to seek approval under the said section, why the resolution has been proposed as an ordinary resolution rather than a special resolution, as mandated under Section 180 of the Companies Act, 2013.
    • Motilal Oswal Mutual FundCompliant with law. Governance and Transparency concern: The Company has not provided an adequate rationale or justification for the proposed transfer/sale of its stake in GTBL to promoter, and it remains unclear how such a transaction qualifies as being in the ordinary course of business of the Company.
    0 for2 against
1 proposal not matched to one resolution
  • To offer, issue and allot in one or more tranches up to 45,95,795 convertible equity warrants, each convertible into, or exchangeable for 1 (one) fully paid-up equity share of the Company of face value of Re. 1/- each (Convertible Equity Warrants) at a price of Rs. 102.87 each {including premium of Rs. 101.87 each payable in cash (Warrants Issue Price), aggregating up to Rs. 47,27,69,432 which may be exercised in one or more tranches during the period commencing from the date of allotment of the Warrants until expiry of 18 (Eighteen) months.MoreLess
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundGovernance and Transparency concern: The Company has not adequately disclosed the specific objective or urgency of the proposed fund raise, thereby limiting shareholders’ ability to assess the necessity of the transaction. Further, the warrants are proposed to be issued at the floor price determined under Chapter V of the SEBI (ICDR) Regulations, 2018 without any premium. Additionally, the Company has not provided sufficient justification for selecting a particular promoter group entity as the allottee, resulting in a lack of clarity on the overall rationale of the proposed issuance.
    0 for2 against

Mutual fund votes, meeting of 12 Sep 2025, 2 fund houses

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2025, together with the Auditors’ Report and Directors’ Report thereon.MoreLess
    2 for0 against
  • To appoint a Director in place of Dr. Adam Demeter (DIN: 10283162) who retires by rotation and being eligible, offers himself for re-appointment.
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundDr. Adam Demeter, 53, serves as the Head of API Manufacturing at Gedeon Richter Plc. Gedeon Richter Investment Management Limited held 9.6% equity in Themis Medicare Ltd. as of June 2025. Gedeon Richter, a Hungarian pharmaceutical company, has been a partner of Themis Medicare Ltd. since 1969. Dr. Adam Demeter attended only one out of seven (14%) board meetings in FY25 and three out of nine (33%) board meetings since his appointment in September 2023. Ms. Reena Patel, his Alternate Director, attended five out of seven board meetings in FY25. We expect directors to personally attend board meetings and do not factor in the attendance of alternate directors. Given his poor attendance, we do not support the resolution.
    1 for1 against
  • To declare a dividend for the financial year ended 31st March, 2025.
    2 for0 against
  • Ratification of Remuneration of Cost Auditor for the Financial Year 2025-26
    2 for0 against
  • Appointment of Secretarial Auditor
    2 for0 against
  • Payment of commission to Non-Executive Directors
    2 for0 against
  • Appointment of Ms. Neha Thakore (DIN: 00893957) as an Independent Director of the Company
    2 for0 against
4 earlier meetings

Mutual fund votes, meeting of 22 Mar 2025, 2 fund houses

  • To approve material Related Party Transactions with Themis Distributors Private Limited for the FY 2025-26
    2 for0 against

Mutual fund votes, meeting of 22 Jul 2024, 1 fund house

  • 1- To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March 2024, together with the Auditors’ Report and Directors’ Report thereon.MoreLess
    1 for0 against
  • 2 - To appoint a Director in place of Mr. Rajneesh Anand (DIN: 00134856) who retires by rotation and being eligible, offers himself for re-appointment.
    1 for0 against
  • 3 - To declare dividend for the financial year ended 31st March, 2024.
    1 for0 against
  • 4 - To ratify the payment of Remuneration to M/s. B. J. D. Nanabhoy & Co., Cost Accountants, Mumbai for conducting Cost Audit of the Company for the financial year 2024-25.
    1 for0 against
  • 5 - Remuneration payable to Dr. Dinesh S. Patel (DIN: 00033273) as a Whole-Time Director designated as “Executive Chairman”.
    1 for0 against
  • 6 - Remuneration payable to Dr. Sachin D. Patel (DIN: 00033353) as Managing Director & CEO.
    1 for0 against
  • 7 - Appointment of Mr. Nikunt Kirit Raval (DIN: 10357559) as an Independent Director of the Company.
    1 for0 against

Mutual fund votes, meeting of 7 Apr 2024, 1 fund house

  • To approve material Related Party Transactions with Themis Distributors Private Limited
    1 for0 against

Mutual fund votes, meeting of 9 Sep 2023, 1 fund house

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March 2023, together with the Auditors’ Report and Directors’ Report thereon.nnMoreLess
    1 for0 against
  • To appoint a Director in place of Mr. Rajneesh Anand (DIN: 00134856) who retires by rotation and being eligible, offers himself for re-appointment.
    1 for0 against
  • To declare dividend for the financial year ended 31st March, 2023.n
    1 for0 against
  • To ratify payment of Remuneration to M/s. B. J. D. Nanabhoy & Co., Cost Accountants, Mumbai for conducting Cost Audit of the Company for the financial year 2023-24.
    1 for0 against
  • Sub-Division (Stock Split) of equity shares of the Company from the Face Value of Rs. 10/- to Face Value of Rs. 1/- per share
    1 for0 against
  • Alteration of Capital Clause of Memorandum of Association of Company.
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Sep 2026.

  • Tax disputeIncome Tax DepartmentSince 11 Nov 2024
    Matter is pending with Commissioner of Income Tax
    At the filing before: Appealed and pending with Authority

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.